Organon jumps on report of $12 bln buyout bid

Organon & Co.

10/04/2026 10:26

** Shares of drugmaker Organon OGN.N rise 8.4% to $7.49 premarket

** India's Sun Pharmaceutical Industries SUN.NS to proceed with $12 billion binding offer for Organon, Economic Times daily reports citing sources

** Sun has completed detailed due diligence over three months and is finalizing a financing package before submitting a firm offer in the coming weeks - ET

** OGN, focused on women's health, did not immediately respond to a Reuters request for comment outside business hours

** Up to last close, OGN down 3.6% YTD

 (Reporting by Sneha S K)

 ((Sneha.SK@thomsonreuters.com;))